Listed

Atara Biotherapeutics, Inc.

ATRANasdaqCIK 1604464HealthcareFiscal year ends Dec 31

Reports and events: 229 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Atara Biotherapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2024-11-1216:10 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-125389
2024-11-1216:05 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-24-125334
2024-10-1516:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-24-237582
2024-09-0516:07 ETSC 13D/AOwnership report, active investor, amended0001104659-24-097369
2024-09-0317:05 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-212168
2024-08-1217:10 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-095533
2024-08-1217:05 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-24-095526
2024-07-1716:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-180371
2024-06-2017:04 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-24-164554
2024-06-1708:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-162069
2024-06-1117:32 ET8-K5.07 Shareholder vote results0001193125-24-158461
2024-05-2218:18 ETSC 13DOwnership report, active investor0001104659-24-064358
2024-05-0916:11 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-056959
2024-05-0916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-056901
2024-04-2616:15 ETDEF 14AProxy statementPeriod 2024-06-100000950170-24-049147
2024-03-2916:30 ET8-K5.02 Departure or appointment of officers or directors0000950170-24-038690
2024-03-2808:40 ET10-KAnnual reportPeriod 2023-12-310000950170-24-037644
2024-03-2808:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-037643
2024-02-2316:30 ET8-K5.02 Departure or appointment of officers or directors0000950170-24-019416
2024-01-0916:01 ET8-K1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits0001193125-24-005188
2024-01-0808:11 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-003945
2023-12-2016:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-071896
2023-11-0921:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-273808
2023-11-0116:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-268185
2023-11-0108:40 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-057147
2023-11-0108:35 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits0000950170-23-057146
2023-09-2018:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-237762
2023-08-0816:13 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-039820
2023-08-0816:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-039797
2023-06-0916:06 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-027257
2023-06-0516:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0000950170-23-026351
2023-05-1216:31 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-021809
2023-05-0816:14 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-018820
2023-05-0816:06 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-23-018793
2023-04-0716:30 ETDEF 14AProxy statement0000950170-23-012204
2023-03-3116:31 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-011416
2023-03-1016:21 ET8-K7.01 Regulation FD disclosure0001193125-23-067628
2023-02-0816:54 ET10-KAnnual reportPeriod 2022-12-310000950170-23-002185
2023-02-0816:02 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-23-002132
2023-01-0616:16 ET8-K2.03 New direct financial obligation0001193125-23-003555
2022-12-2016:42 ET8-K1.01 Entry into a material agreement0001193125-22-309181
2022-12-1908:05 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001193125-22-307898
2022-11-0816:20 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-023248
2022-11-0816:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-023226
2022-09-2816:30 ET8-K1.01 Entry into a material agreement0001193125-22-253304
2022-09-2716:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-22-252141
2022-08-0816:14 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-015536
2022-08-0816:07 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-22-015519
2022-06-2416:02 ET8-K5.07 Shareholder vote results0001193125-22-181461
2022-05-1916:05 ET8-K1.02 Termination of a material agreement0001193125-22-155021

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 02:48 ET. Listed shows no prices and gives no investment advice.